On the public citation graph

Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease

https://doi.org/10.1021/acsinfecdis.0c00168

0 signed · 337 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/aps3.1205openalex-snapshot

Isolation and characterization of microsatellite loci from Pterocarya stenoptera (Juglandaceae)

inferredcites →https://doi.org/10.1002/med.21475openalex-snapshot

Proteases and protease inhibitors in infectious diseases

inferredcites →https://doi.org/10.1007/978-1-4939-2438-7_1openalex-snapshot

Coronaviruses: An Overview of Their Replication and Pathogenesis

inferredcites →https://doi.org/10.1007/978-1-4939-7231-9_4openalex-snapshot

Protein Structure Modeling with MODELLER

inferredcites →https://doi.org/10.1007/978-1-60327-058-8_8openalex-snapshot

Protein Structure Modeling with MODELLER

inferredcites →https://doi.org/10.1016/j.antiviral.2014.12.015openalex-snapshot

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds

inferredcites →https://doi.org/10.1016/j.antiviral.2019.104661openalex-snapshot

Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease

inferredcites →https://doi.org/10.1016/j.celrep.2017.08.040openalex-snapshot

Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease

inferredcites →https://doi.org/10.1016/j.chom.2007.09.014openalex-snapshot

Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses

inferredcites →https://doi.org/10.1016/j.jmb.2017.04.011openalex-snapshot

Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species

inferredcites →https://doi.org/10.1016/j.jmb.2019.03.013openalex-snapshot

ISG15: It's Complicated

inferredcites →https://doi.org/10.1016/j.jviromet.2012.05.030openalex-snapshot

Development and optimization of a direct plaque assay for human and avian metapneumoviruses

inferredcites →https://doi.org/10.1016/j.molcel.2016.04.016openalex-snapshot

Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease

inferredcites →https://doi.org/10.1016/j.virol.2014.02.026openalex-snapshot

The vOTU domain of highly-pathogenic porcine reproductive and respiratory syndrome virus displays a differential substrate preference

inferredcites →https://doi.org/10.1016/j.virol.2015.02.033openalex-snapshot

Ubiquitination in the antiviral immune response

inferredcites →https://doi.org/10.1021/cb500917mopenalex-snapshot

Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV

inferredcites →https://doi.org/10.1021/jm401712topenalex-snapshot

X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases

inferredcites →https://doi.org/10.1021/jm900611topenalex-snapshot

Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease

inferredcites →https://doi.org/10.1038/ncomms12754openalex-snapshot

Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins

inferredcites →https://doi.org/10.1038/nmeth.1649openalex-snapshot

Protein standard absolute quantification (PSAQ) method for the measurement of cellular ubiquitin pools

inferredcites →https://doi.org/10.1038/nri2314openalex-snapshot

Interferon-inducible antiviral effectors

inferredcites →https://doi.org/10.1038/s41564-020-0695-zopenalex-snapshot

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

inferredcites →https://doi.org/10.1073/pnas.0504754102openalex-snapshot

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

inferredcites →https://doi.org/10.1073/pnas.0510851103openalex-snapshot

Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme

inferredcites →https://doi.org/10.1073/pnas.0805240105openalex-snapshot

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

inferredcites →https://doi.org/10.1073/pnas.1218464110openalex-snapshot

Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells

inferredcites →https://doi.org/10.1074/jbc.c109.095703openalex-snapshot

Species Specificity of the NS1 Protein of Influenza B Virus

inferredcites →https://doi.org/10.1074/jbc.m114.609644openalex-snapshot

Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression

inferredcites →https://doi.org/10.1074/jbc.m115.662130openalex-snapshot

X-ray Structural and Functional Studies of the Three Tandemly Linked Domains of Non-structural Protein 3 (nsp3) from Murine Hepatitis Virus Reveal Conserved Functions

inferredcites →https://doi.org/10.1074/jbc.m704870200openalex-snapshot

Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus

inferredcites →https://doi.org/10.1107/s2059798318015322openalex-snapshot

Structure of interferon-stimulated gene product 15 (ISG15) from the bat species Myotis davidii and the impact of interdomain ISG15 interactions on viral protein engagement

inferredcites →https://doi.org/10.1128/jvi.00338-15openalex-snapshot

Murine Coronavirus Ubiquitin-Like Domain Is Important for Papain-Like Protease Stability and Viral Pathogenesis

inferredcites →https://doi.org/10.1128/jvi.00975-16openalex-snapshot

Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species

inferredcites →https://doi.org/10.1128/jvi.01067-17openalex-snapshot

Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus

inferredcites →https://doi.org/10.1128/jvi.01294-14openalex-snapshot

Catalytic Function and Substrate Specificity of the Papain-Like Protease Domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus

inferredcites →https://doi.org/10.1128/jvi.01734-19openalex-snapshot

Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus

inferredcites →https://doi.org/10.1128/jvi.02220-08openalex-snapshot

Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

inferredcites →https://doi.org/10.1128/jvi.02395-09openalex-snapshot

Species-Specific Antagonism of Host ISGylation by the Influenza B Virus NS1 Protein

inferredcites →https://doi.org/10.1128/jvi.03252-12openalex-snapshot

Diversity of Ubiquitin and ISG15 Specificity among Nairoviruses' Viral Ovarian Tumor Domain Proteases

inferredcites →https://doi.org/10.1128/jvi.79.24.15189-15198.2005openalex-snapshot

The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity

inferredcites →https://doi.org/10.1371/journal.pone.0226415openalex-snapshot

Determining the molecular drivers of species-specific interferon-stimulated gene product 15 interactions with nairovirus ovarian tumor domain proteases

inferredcites →https://doi.org/10.1371/journal.ppat.1004113openalex-snapshot

Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease

inferredcites →https://doi.org/10.1371/journal.ppat.1005531openalex-snapshot

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor

inferredcites →https://doi.org/10.1371/journal.ppat.1007515openalex-snapshot

Probing the impact of nairovirus genomic diversity on viral ovarian tumor domain protease (vOTU) structure and deubiquitinase activity

inferredcites →https://doi.org/10.2305/iucn.uk.2019-3.rlts.t136250a22003049.enopenalex-snapshot

Myotis davidii: Jiang, T.L. & Feng, J.

inferredcites →https://doi.org/10.3201/eid2606.200516openalex-snapshot

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

inferredcites →https://doi.org/10.3390/v10120727openalex-snapshot

SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus)

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1016/j.phytochem.2021.112984zenodo-depositor-declared

Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1002/1873-3468.70063openalex-snapshot

Interferon‐induced protein ISG15 in the central nervous system, quo vadis?

inferred← citeshttps://doi.org/10.1002/advs.202002484openalex-snapshot

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity

inferred← citeshttps://doi.org/10.1002/ange.202016113openalex-snapshot

Eine Strategie zur Ligandenselektion identifiziert chemische Sonden für die Markierung von SARS‐CoV‐2‐Proteasen

inferred← citeshttps://doi.org/10.1002/ange.202212378openalex-snapshot

Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS‐CoV‐2 Papain‐Like Protease**

inferred← citeshttps://doi.org/10.1002/anie.202016113openalex-snapshot

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS‐CoV‐2

inferred← citeshttps://doi.org/10.1002/anie.202212378openalex-snapshot

Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS‐CoV‐2 Papain‐Like Protease**

inferred← citeshttps://doi.org/10.1002/cbic.202200327openalex-snapshot

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

inferred← citeshttps://doi.org/10.1002/chem.71248openalex-snapshot

Substrate‐Selective Inhibition of the SARS‐CoV‐2 Papain‐Like Protease: Inhibition of Hydrolysis of Human Over Viral Substrates

inferred← citeshttps://doi.org/10.1002/cmdc.202000548openalex-snapshot

Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2

inferred← citeshttps://doi.org/10.1002/cmdc.202200016openalex-snapshot

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease

inferred← citeshttps://doi.org/10.1002/iub.2379openalex-snapshot

SARS‐CoV ‐2 multifaceted interaction with the human host. Part II : Innate immunity response, immunopathology, and epigenetics

inferred← citeshttps://doi.org/10.1002/jmv.26497openalex-snapshot

The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics

inferred← citeshttps://doi.org/10.1002/jmv.26814openalex-snapshot

Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐19

inferred← citeshttps://doi.org/10.1002/jmv.70448openalex-snapshot

Papain‐Like Protease of SARS‐CoV‐2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors

inferred← citeshttps://doi.org/10.1002/jmv.70589openalex-snapshot

Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections

inferred← citeshttps://doi.org/10.1002/mco2.254openalex-snapshot

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2

inferred← citeshttps://doi.org/10.1002/med.21776openalex-snapshot

Therapeutic targets and potential agents for the treatment of COVID‐19

inferred← citeshttps://doi.org/10.1002/med.21919openalex-snapshot

Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs

inferred← citeshttps://doi.org/10.1002/nzb2.70039openalex-snapshot

Are Tetrapleura tetraptera Phytochemicals Druggable Against SARS‐CoV‐2 Papain‐Like Protein? A Computational Approach

inferred← citeshttps://doi.org/10.1002/ptr.7084openalex-snapshot

Phyto‐pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID ‐19, based on its promising immunomodulatory, anti‐coagulant and anti‐viral property

inferred← citeshttps://doi.org/10.1007/7355_2026_193openalex-snapshot

Focus on SARS-CoV-2 Proteases: Structure, Function, and Inhibitor Development

inferred← citeshttps://doi.org/10.1007/7653_2020_64openalex-snapshot

Molecular-Level Targets for the Development of Therapies Against Coronavirus Diseases

inferred← citeshttps://doi.org/10.1007/978-981-99-3664-9_4openalex-snapshot

Herbal Formulations in Fighting Against the SARS-CoV-2 Infection

inferred← citeshttps://doi.org/10.1007/s00706-024-03271-8openalex-snapshot

Molecular insights into natural product compounds targeting papain protease of SARS-CoV-2 through molecular dynamics simulation

inferred← citeshttps://doi.org/10.1007/s10822-021-00432-3openalex-snapshot

Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking

inferred← citeshttps://doi.org/10.1007/s11030-021-10198-3openalex-snapshot

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery

inferred← citeshttps://doi.org/10.1007/s11030-022-10394-9openalex-snapshot

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations

inferred← citeshttps://doi.org/10.1007/s11030-023-10601-1openalex-snapshot

Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds

inferred← citeshttps://doi.org/10.1007/s11418-024-01788-0openalex-snapshot

Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro

inferred← citeshttps://doi.org/10.1007/s11696-025-03968-yopenalex-snapshot

Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation

inferred← citeshttps://doi.org/10.1007/s12033-021-00383-yopenalex-snapshot

Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors

inferred← citeshttps://doi.org/10.1007/s12275-022-1499-zopenalex-snapshot

Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants

inferred← citeshttps://doi.org/10.1016/b978-0-323-90248-9.00011-5openalex-snapshot

Fundamental aspects of the structural biology of coronaviruses

inferred← citeshttps://doi.org/10.1016/j.abb.2026.110840openalex-snapshot

Specificity profiling of SARS-CoV-2 PLpro using proteome-derived libraries of linear peptides suggests secondary preference for basic motifs

inferred← citeshttps://doi.org/10.1016/j.apsb.2020.08.014openalex-snapshot

Crystal structure of SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1016/j.apsb.2021.06.016openalex-snapshot

Recent advances in developing small-molecule inhibitors against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.11.083openalex-snapshot

Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors

inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.08.003openalex-snapshot

Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation

inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114225openalex-snapshot

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches

inferred← citeshttps://doi.org/10.1016/j.biochi.2021.02.012openalex-snapshot

SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators

inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110377openalex-snapshot

Fragment-based discovery of novel Baicalein derivatives as triple-target 3CLpro/PLpro/RdRp inhibitors against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111313openalex-snapshot

An update review of emerging small-molecule therapeutic options for COVID-19

inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114247openalex-snapshot

Computer-aided drug design for the pain-like protease (PLpro) inhibitors against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116378openalex-snapshot

Novel nitric oxide donors are coronary vasodilators that also bind to the papain-like protease of SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.bmc.2020.115860openalex-snapshot

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

inferred← citeshttps://doi.org/10.1016/j.bmc.2023.117498openalex-snapshot

Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification

inferred← citeshttps://doi.org/10.1016/j.bmc.2024.117909openalex-snapshot

Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships

inferred← citeshttps://doi.org/10.1016/j.bmcl.2023.129489openalex-snapshot

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

inferred← citeshttps://doi.org/10.1016/j.bmcl.2025.130168openalex-snapshot

Research progress on critical viral protease inhibitors for coronaviruses and enteroviruses

inferred← citeshttps://doi.org/10.1016/j.cellsig.2022.110559openalex-snapshot

COVID-19 signalome: Potential therapeutic interventions

inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109754openalex-snapshot

A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1016/j.chembiol.2021.04.020openalex-snapshot

Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.chemphys.2022.111709openalex-snapshot

Searching for potential inhibitors of SARS-COV-2 main protease using supervised learning and perturbation calculations

inferred← citeshttps://doi.org/10.1016/j.chphi.2021.100011openalex-snapshot

Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104295openalex-snapshot

Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104406openalex-snapshot

Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective

inferred← citeshttps://doi.org/10.1016/j.cplett.2020.138068openalex-snapshot

Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study

inferred← citeshttps://doi.org/10.1016/j.cplett.2021.138468openalex-snapshot

Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies

inferred← citeshttps://doi.org/10.1016/j.csbj.2021.07.023openalex-snapshot

Immune evasion of SARS-CoV-2 from interferon antiviral system

inferred← citeshttps://doi.org/10.1016/j.csbj.2021.08.036openalex-snapshot

An overview of potential inhibitors targeting non-structural proteins 3 (PL pro and Mac1) and 5 (3CL pro /M pro ) of SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.csbj.2021.09.022openalex-snapshot

Polyphenols as alternative treatments of COVID-19

inferred← citeshttps://doi.org/10.1016/j.drudis.2023.103832openalex-snapshot

Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery

inferred← citeshttps://doi.org/10.1016/j.ejmcr.2024.100173openalex-snapshot

Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics

inferred← citeshttps://doi.org/10.1016/j.ejmcr.2025.100306openalex-snapshot

Design, synthesis, and binding analysis of target-specific covalent inhibitors of SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113294openalex-snapshot

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115380openalex-snapshot

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115978openalex-snapshot

Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism

inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118698openalex-snapshot

Integration of computational and experimental techniques for the discovery of PLpro covalent inhibitors. When large virtual screening and rational design meet

inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.173705openalex-snapshot

Functional and druggability analysis of the SARS-CoV-2 proteome

inferred← citeshttps://doi.org/10.1016/j.fbio.2024.105095openalex-snapshot

Viola stocksii: A rich source of antioxidant and anti-inflammatory flavonoid glycosides with converged therapeutic potential against SARS-CoV-2 MPro, spike trimer, and surface glycoproteins

inferred← citeshttps://doi.org/10.1016/j.fct.2020.111805openalex-snapshot

Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic

inferred← citeshttps://doi.org/10.1016/j.fmre.2021.01.013openalex-snapshot

Drug discovery and development targeting the life cycle of SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.gene.2024.148377openalex-snapshot

SARS-CoV-2 and UPS with potentials for therapeutic interventions

inferred← citeshttps://doi.org/10.1016/j.heliyon.2020.e05558openalex-snapshot

Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19

inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e06657openalex-snapshot

Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e33179openalex-snapshot

Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.09.204openalex-snapshot

Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.123347openalex-snapshot

Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.124772openalex-snapshot

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.134850openalex-snapshot

Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics

inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107220openalex-snapshot

COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus

inferred← citeshttps://doi.org/10.1016/j.isci.2021.103213openalex-snapshot

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro

inferred← citeshttps://doi.org/10.1016/j.isci.2024.109593openalex-snapshot

Type I interferon regulation by USP18 is a key vulnerability in cancer

inferred← citeshttps://doi.org/10.1016/j.jaut.2021.102644openalex-snapshot

An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19

inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102250openalex-snapshot

Crystal structure of the Rubella virus protease reveals a unique papain-like protease fold

inferred← citeshttps://doi.org/10.1016/j.jbc.2023.105346openalex-snapshot

SARS-CoV-2 papain-like protease plays multiple roles in regulating cellular proteins in the endoplasmic reticulum

inferred← citeshttps://doi.org/10.1016/j.jmb.2020.11.024openalex-snapshot

Structural insights into SARS-CoV-2 proteins

inferred← citeshttps://doi.org/10.1016/j.jmgm.2021.107851openalex-snapshot

Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay

inferred← citeshttps://doi.org/10.1016/j.mcp.2024.101973openalex-snapshot

SARS-CoV-2 replication and drug discovery

inferred← citeshttps://doi.org/10.1016/j.mib.2024.102466openalex-snapshot

Differences and similarities between innate immune evasion strategies of human coronaviruses

inferred← citeshttps://doi.org/10.1016/j.micpath.2020.104641openalex-snapshot

Structural and functional insights into non-structural proteins of coronaviruses

inferred← citeshttps://doi.org/10.1016/j.molstruc.2021.130366openalex-snapshot

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.132915openalex-snapshot

Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via in silico studies

inferred← citeshttps://doi.org/10.1016/j.pep.2023.106267openalex-snapshot

Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1016/j.phymed.2022.154324openalex-snapshot

A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19

inferred← citeshttps://doi.org/10.1016/j.phyplu.2022.100402openalex-snapshot

Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases

inferred← citeshttps://doi.org/10.1016/j.phytol.2025.103010openalex-snapshot

Isolation and computational characterization of a novel cyanogenic glucoside from Centaurea microcarpa with antiviral potential against SARS-CoV-2: DFT, ADMET, and molecular docking analysis

inferred← citeshttps://doi.org/10.1016/j.rechem.2025.102851openalex-snapshot

Identification of selective protease inhibitors by using virtual screening, molecular dynamics simulation for SARS CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1016/j.sjbs.2021.09.028openalex-snapshot

Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies

inferred← citeshttps://doi.org/10.1016/j.slast.2026.100409openalex-snapshot

Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination

inferred← citeshttps://doi.org/10.1016/j.tips.2022.08.008openalex-snapshot

Targeting SARS-CoV-2 papain-like protease in the postvaccine era

inferred← citeshttps://doi.org/10.1016/j.virol.2023.02.011openalex-snapshot

Genetic conservation across SARS-CoV-2 non-structural proteins – Insights into possible targets for treatment of future viral outbreaks

inferred← citeshttps://doi.org/10.1016/j.virs.2023.04.008openalex-snapshot

Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase

inferred← citeshttps://doi.org/10.1016/j.virusres.2024.199368openalex-snapshot

Viral deubiquitinating proteases and the promising strategies of their inhibition

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01140openalex-snapshot

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00566openalex-snapshot

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01307openalex-snapshot

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00303openalex-snapshot

Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00378openalex-snapshot

Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00534openalex-snapshot

Design, Synthesis, and Biological Evaluation of 1,2,4-Oxadiazole Derivatives Containing an Aryl Carboxylic Acid Moiety as Potent Sarbecovirus Papain-like Protease Inhibitors

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c03846openalex-snapshot

Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1–114: From Structure-Based Design to In Vivo Antiviral Efficacy

inferred← citeshttps://doi.org/10.1021/acs.jpcb.1c07060openalex-snapshot

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease

inferred← citeshttps://doi.org/10.1021/acs.jpclett.1c00831openalex-snapshot

Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein

inferred← citeshttps://doi.org/10.1021/acs.jproteome.0c00779openalex-snapshot

Molecular Basis of SARS-CoV‑2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches

inferred← citeshttps://doi.org/10.1021/acs.jproteome.5c01277openalex-snapshot

Computationally Efficient Bayesian Estimation of Graphical Networks for Omics Data

inferred← citeshttps://doi.org/10.1021/acscentsci.1c00519openalex-snapshot

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00815openalex-snapshot

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19

inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00866openalex-snapshot

The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease

inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00631openalex-snapshot

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses

inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00458openalex-snapshot

Identification of Human Host Substrates of the SARS-CoV-2 Mpro and PLpro Using Subtiligase N-Terminomics

inferred← citeshttps://doi.org/10.1021/acsinfecdis.4c00444openalex-snapshot

Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets

inferred← citeshttps://doi.org/10.1021/acsomega.2c06675openalex-snapshot

Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease

inferred← citeshttps://doi.org/10.1021/acsomega.4c02392openalex-snapshot

Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products

inferred← citeshttps://doi.org/10.1021/acsptsci.0c00130openalex-snapshot

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors

inferred← citeshttps://doi.org/10.1021/acsptsci.1c00099openalex-snapshot

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir

inferred← citeshttps://doi.org/10.1021/acsptsci.1c00240openalex-snapshot

Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors

inferred← citeshttps://doi.org/10.1038/s41467-020-20718-8openalex-snapshot

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery

inferred← citeshttps://doi.org/10.1038/s41467-023-37254-wopenalex-snapshot

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

inferred← citeshttps://doi.org/10.1038/s41580-022-00543-1openalex-snapshot

An expanded lexicon for the ubiquitin code

inferred← citeshttps://doi.org/10.1038/s41586-020-2601-5openalex-snapshot

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

inferred← citeshttps://doi.org/10.1038/s41598-021-84782-wopenalex-snapshot

The in-vitro effect of famotidine on SARS-CoV-2 proteases and virus replication

inferred← citeshttps://doi.org/10.1038/s41598-022-18676-wopenalex-snapshot

Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts

inferred← citeshttps://doi.org/10.1038/s41598-023-35907-wopenalex-snapshot

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase

inferred← citeshttps://doi.org/10.1038/s41598-025-01425-0openalex-snapshot

Spermidine reduces ISGylation and enhances ISG15–USP18 interaction

inferred← citeshttps://doi.org/10.1039/d1ra05976aopenalex-snapshot

Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening

inferred← citeshttps://doi.org/10.1039/d1ra07092dopenalex-snapshot

One-pot synthesis of new alkyl 1-naphthoates bearing quinoline, pyranone and cyclohexenone moieties via metal-free sequential addition/oxidation reactions

inferred← citeshttps://doi.org/10.1039/d1ra08752eopenalex-snapshot

Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 M pro

inferred← citeshttps://doi.org/10.1039/d2cp04476eopenalex-snapshot

Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro via physics- and knowledge-based approaches

inferred← citeshttps://doi.org/10.1039/d3cb00128hopenalex-snapshot

Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein

inferred← citeshttps://doi.org/10.1039/d3ra01915bopenalex-snapshot

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication

inferred← citeshttps://doi.org/10.1039/d3sc00166kopenalex-snapshot

Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches

inferred← citeshttps://doi.org/10.1042/bcj20200514openalex-snapshot

The role of chemical biology in the fight against SARS-CoV-2

inferred← citeshttps://doi.org/10.1042/bcj20210197openalex-snapshot

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease

inferred← citeshttps://doi.org/10.1042/bcj20210244openalex-snapshot

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease

inferred← citeshttps://doi.org/10.1042/bst20200396openalex-snapshot

A pocket guide on how to structure SARS-CoV-2 drugs and therapies

inferred← citeshttps://doi.org/10.1080/07391102.2020.1823887openalex-snapshot

The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach

inferred← citeshttps://doi.org/10.1080/07391102.2021.1953601openalex-snapshot

Protein degradation: a novel computational approach to design protein degrader probes for main protease of SARS-CoV-2

inferred← citeshttps://doi.org/10.1080/07391102.2021.1958700openalex-snapshot

Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors

inferred← citeshttps://doi.org/10.1080/07391102.2023.2173297openalex-snapshot

Computational design of candidate multi-epitope vaccine against SARS-CoV-2 targeting structural (S and N) and non-structural (NSP3 and NSP12) proteins

inferred← citeshttps://doi.org/10.1080/07391102.2023.2240424openalex-snapshot

Reconstruction of the unbinding pathways of new inhibitors of the SARS-CoV-2 papain-like protease using molecular dynamics simulation

inferred← citeshttps://doi.org/10.1080/0889311x.2022.2098281openalex-snapshot

The Swiss army knife of SARS-CoV-2: the structures and functions of NSP3

inferred← citeshttps://doi.org/10.1080/08927022.2021.1957884openalex-snapshot

An in silico molecular dynamics simulation study on the inhibitors of SARS-CoV-2 proteases (3CLpro and PLpro) to combat COVID-19

inferred← citeshttps://doi.org/10.1080/1062936x.2021.1960601openalex-snapshot

Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations

inferred← citeshttps://doi.org/10.1080/10826068.2025.2456940openalex-snapshot

Improving soluble recombinant SARS-CoV-2 papain-like protease production in Escherichia coli through chaperonin and maltose-binding protein tag: purification and kinetic characterization

inferred← citeshttps://doi.org/10.1080/13543776.2021.1857726openalex-snapshot

Protease inhibitors targeting the main protease and papain-like protease of coronaviruses

inferred← citeshttps://doi.org/10.1080/14756366.2024.2301772openalex-snapshot

Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis

inferred← citeshttps://doi.org/10.1080/15548627.2024.2442849openalex-snapshot

Regulation of N-degron recognin-mediated autophagy by the SARS-CoV-2 PLpro ubiquitin deconjugase

inferred← citeshttps://doi.org/10.1083/jcb.202006159openalex-snapshot

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

inferred← citeshttps://doi.org/10.1093/bib/bbaa422openalex-snapshot

Ligand-based approach for predicting drug targets and for virtual screening against COVID-19

inferred← citeshttps://doi.org/10.1093/nar/gkaa861openalex-snapshot

DockCoV2: a drug database against SARS-CoV-2

inferred← citeshttps://doi.org/10.1093/nar/gkad944openalex-snapshot

The IUPHAR/BPS Guide to PHARMACOLOGY in 2024

inferred← citeshttps://doi.org/10.1093/procel/pwac016openalex-snapshot

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors

inferred← citeshttps://doi.org/10.1098/rsos.211480openalex-snapshot

Unbinding ligands from SARS-CoV-2 Mpro via umbrella sampling simulations

inferred← citeshttps://doi.org/10.1101/2020.08.30.273979openalex-snapshot

Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PL pro and M pro in in vitro studies

inferred← citeshttps://doi.org/10.1101/2020.12.27.424507openalex-snapshot

Losartan promotes cell survival following SARS-CoV-2 infection in vitro

inferred← citeshttps://doi.org/10.1101/2021.03.02.433434openalex-snapshot

High-content screening of coronavirus genes for innate immune suppression reveals enhanced potency of SARS-CoV-2 proteins

inferred← citeshttps://doi.org/10.1101/2022.03.30.486313openalex-snapshot

Identification of C270 as a novel site for allosteric modulators of SARS-CoV-2 papain-like protease

inferred← citeshttps://doi.org/10.1101/2023.03.23.533924openalex-snapshot

Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function

inferred← citeshttps://doi.org/10.1107/s205979832100509xopenalex-snapshot

Structural insights into the interaction of papain-like protease 2 from the alphacoronavirus porcine epidemic diarrhea virus and ubiquitin

inferred← citeshttps://doi.org/10.1111/cbdd.14115openalex-snapshot

Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain‐Like cysteine proteases of SARS‐CoV‐2

inferred← citeshttps://doi.org/10.1111/sji.13044openalex-snapshot

Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19

inferred← citeshttps://doi.org/10.1126/sciadv.abd4596openalex-snapshot

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design

inferred← citeshttps://doi.org/10.1126/sciadv.ado4288openalex-snapshot

Discovery of SARS-CoV-2 papain-like protease (PL pro ) inhibitors with efficacy in a murine infection model

inferred← citeshttps://doi.org/10.1126/scisignal.add0082openalex-snapshot

The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING

inferred← citeshttps://doi.org/10.1126/scisignal.ade1985openalex-snapshot

The substrate selectivity of papain-like proteases from human-infecting coronaviruses correlates with innate immune suppression

inferred← citeshttps://doi.org/10.1128/aac.02577-20openalex-snapshot

Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2

inferred← citeshttps://doi.org/10.1128/jvi.00857-26openalex-snapshot

A chimeric murine coronavirus with altered deISGylase and proteolytic activities exhibits attenuated viral pathogenesis

inferred← citeshttps://doi.org/10.1128/jvi.01734-19openalex-snapshot

Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus

inferred← citeshttps://doi.org/10.1128/spectrum.00744-22openalex-snapshot

Expression Profile and Localization of SARS-CoV-2 Nonstructural Replicase Proteins in Infected Cells

inferred← citeshttps://doi.org/10.1134/s0006350922060082openalex-snapshot

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions

inferred← citeshttps://doi.org/10.11606/d.60.2021.tde-22032022-092001openalex-snapshot

Explorando a diversidade química de fungos fitoparasitas de frutos e avaliação de seus potenciais inibitórios de papaína

inferred← citeshttps://doi.org/10.1172/jci161453openalex-snapshot

Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure

inferred← citeshttps://doi.org/10.1177/2472555220960428openalex-snapshot

Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3

inferred← citeshttps://doi.org/10.1177/2472555220963667openalex-snapshot

High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2

inferred← citeshttps://doi.org/10.1186/s12863-022-01044-yopenalex-snapshot

Predicted coronavirus Nsp5 protease cleavage sites in the human proteome

inferred← citeshttps://doi.org/10.1186/s40816-022-00347-yopenalex-snapshot

Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain-like protease and 3-chymotrypsin-like protease of SARS-CoV-2

inferred← citeshttps://doi.org/10.1186/s43141-021-00152-zopenalex-snapshot

Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics

inferred← citeshttps://doi.org/10.1246/bcsj.20220179openalex-snapshot

Molecular Mechanisms of the Medicines for COVID-19

inferred← citeshttps://doi.org/10.1248/cpb.c23-00622openalex-snapshot

In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease

inferred← citeshttps://doi.org/10.1371/journal.pcbi.1010667openalex-snapshot

Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding

inferred← citeshttps://doi.org/10.1371/journal.pone.0253364openalex-snapshot

Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies

inferred← citeshttps://doi.org/10.1371/journal.pone.0309305openalex-snapshot

A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals

inferred← citeshttps://doi.org/10.1371/journal.ppat.1009013openalex-snapshot

The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

inferred← citeshttps://doi.org/10.1371/journal.ppat.1012100openalex-snapshot

Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo

inferred← citeshttps://doi.org/10.1515/pac-2026-0807openalex-snapshot

Development of SARS-CoV-2 papain-like protease inhibitors with a thiadiazole and oxadiazole linker

inferred← citeshttps://doi.org/10.15252/embj.2020106275openalex-snapshot

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2

inferred← citeshttps://doi.org/10.1590/0074-02760210127openalex-snapshot

The adaptation of SARS-CoV-2 to humans

inferred← citeshttps://doi.org/10.18004/anales/2020.053.03.131openalex-snapshot

Potential therapeutic agents against COVID-19 based on blocking and inhibition of the viral life cycle and the cytokine storm syndrome

inferred← citeshttps://doi.org/10.18433/jpps31931openalex-snapshot

Losartan Inhibits SARS-CoV-2 Replication in Vitro

showing the first 200 of 290

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.